Gwanyoung Kim, Hyun-ki Moon, Taeheon Kim, So-hye Yun, Hwi-yeol Yun, Jang Hee Hong, & Dae-Duk Kim. (2023). Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study. MDPI AG.
Chicago Style (17th ed.) CitationGwanyoung Kim, Hyun-ki Moon, Taeheon Kim, So-hye Yun, Hwi-yeol Yun, Jang Hee Hong, and Dae-Duk Kim. Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study. MDPI AG, 2023.
MLA (9th ed.) CitationGwanyoung Kim, et al. Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.